AstraZeneca's contract with the European Union foresaw an initial 300 million doses for distribution among the 27 member countries, with option for a further 100 million.
He said that the reason for the legal action was that "some terms of the contract have not been respected" and that "the company has not been in a position to come up with a reliable strategy to ensure a timely delivery of doses." The commission — which has been responsible for procuring vaccines for all of the bloc — informed member states last week of its plans to take the company to court and pressed for support from national governments.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: